Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...

Mycology reveals fungi's potential in mycoremediation, sustainable construction, and psilocybin research, addressing key ...

PDS Biotechnology (NASDAQ:PDSB) outlined plans to advance its investigational immunocytokine PDS0301 into a Phase III study ...

The proposed restrictions would cover 14 technologies in industries ranging from artificial intelligence to photovoltaic solar power China on Friday unveiled a draft plan to impose new export bans ...

Veteran oncology regulator brings more than 25 years of FDA experience as Siren advances SRN-101 into clinical developmentSAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, a ...

Vir Biotechnology Inc. VIR announced a major collaboration with Gilead Sciences Inc. GILD to create three novel T-cell ...

T-cell engagers are designed to direct the body's immune system to recognize and attack cancer cells. Vir's PRO-XTEN technology is intended to keep these therapies inactive until they reach the tumor ...

The Defense Innovation Networking Group (D!NG) today announced that the submission window is officially open for the ...

Summary] Taking the success of 'BioJapan 2026,' held in October 2026, as an opportunity to reflect on the historical ...

Researchers identify GmRVE4d as a gene that delays soybean flowering and maturity by repressing GmPRR5a. This finding highlights GmRVE4d as a potential breeding target for improving soybean adaptation ...

SAN CARLOS, CA / ACCESS Newswire / October 8, 2026 / Marquis Who's Who is proud to interview and honor Anthony B. Chen, ...

Cold-adapted lipases have attracted extensive research attention in enzymology owing to their unique low-temperature adaptability and catalytic properties, and investigations in this area continue to ...